US FDA approves Mallinckrodt’s Terlivaz for injection to treat hepatorenal syndrome

Terlivaz is indicated to improve to improve kidney function in hepatorenal syndrome (HRS) adult patients with rapid reduction in kidney function. Credit: Nephron/ commons.wikimedia.org.